Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study - Abraham,E.; Reinhart,K.; Svoboda,P. (Crit Care Med, 2001)